- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Nano Cap Stocks
Hong Kong Pharmaceuticals & Biotech Nano Cap Stocks
Results
5
Stocks with a market cap under US$50M.
5 companies
Austar Lifesciences
Market Cap: HK$384.4m
An investment holding company, provides integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.75
7D
4.2%
1Y
-43.2%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$323.2m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.29
7D
3.6%
1Y
-7.9%
Shenzhen Neptunus Interlong Bio-technique
Market Cap: HK$186.3m
Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.
8329
HK$0.11
7D
3.8%
1Y
-31.0%
Kontafarma China Holdings
Market Cap: HK$167.7m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediates in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.03
7D
7.1%
1Y
0%
China Regenerative Medicine International
Market Cap: HK$71.5m
Engages in the research, development, production, and sale of tissue engineering and regenerative medicine products in Hong Kong and China.
8158
HK$0.23
7D
1.3%
1Y
-73.3%